Orange Book product · Generic (ANDA)
CICLOPIROX
CICLOPIROX
At a glance
Aug 06, 2004
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Aug 06, 2004
22 yr 2 mo ago
Today
Pharmaceutical detail
Active ingredient
CICLOPIROX
Strength
0.77%
Dosage form
SUSPENSION
Route
TOPICAL
TE code
AB
Application
ANDA 076422
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of CICLOPIROX
- 2003LOPROXBrand (NDA)
NDA 021159 · BAUSCH
- 1999PENLACBrand (NDA)
NDA 021022 · VALEANT BERMUDA
- 1997CICLOPIROXBrand (NDA)
NDA 020519 · ALVOGEN
- 1988LOPROXBrand (NDA)
NDA 019824 · EUROFARMA
- 1982LOPROXBrand (NDA)
NDA 018748 · EUROFARMA
- 2018CICLOPIROXGeneric (ANDA)
ANDA 209975 · ENCUBE
- 2012CICLOPIROXGeneric (ANDA)
ANDA 091595 · GLENMARK PHARMS
- 2011CICLOPIROXGeneric (ANDA)
ANDA 090269 · SUN PHARMA CANADA
- 2010CICLOPIROXGeneric (ANDA)
ANDA 078463 · COSETTE PHARMS NC
- 2010CICLOPIROXGeneric (ANDA)
ANDA 090146 · FOUGERA PHARMS
- 2010CICLOPIROXGeneric (ANDA)
ANDA 078975 · EPIC PHARMA LLC
- 2010CICLOPIROXGeneric (ANDA)
ANDA 078594 · PADAGIS US
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
